Effect of Successful Direct Acting Antivirals Therapy on Liver Stiffness in Patients with Chronic HCV Infection
Background: Achievement of sustained virological response [SVR] and improvement of hepatic fibrosis are the essential goals for therapy of chronic hepatitis C [CHC] with direct acting antivirals [DAAs] therapy. Early detection and management of hepatic fibrosis can significantly improve the prognosi...
Enregistré dans:
Auteurs principaux: | Ibrahim Anam Ezzelregal, Fathya Mostafa Elraie, Khalid Elmola, Mostafa Mohamed Shaqueer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Al-Azhar University, Faculty of Medicine (Damietta)
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5f91c58e0404426980b546aa7545d7b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
par: María E. Cárdaba-García, et autres
Publié: (2021) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
par: Vicente Soriano, et autres
Publié: (2022) -
Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement
par: Tag-Adeen M, et autres
Publié: (2017) -
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
par: Cesare Mazzaro, et autres
Publié: (2021) -
‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
par: Fabrizio Fabrizi, et autres
Publié: (2021)